PIII (P3 Health Partners) Revenue: $1,472 Mil (TTM As of Mar. 2026)


PIII P3 Health Partners Inc PIII
44 GF Score
Price $10.59
GF Value $9.07
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is P3 Health Partners Revenue?

P3 Health Partners PIII +8.06% 44 Revenue is $1,472 Mil as of Mar. 2026. GuruFocus rates PIII with a GF Score™ of 44/100 and a GF Value™ of $9.07 (Modestly Overvalued). The stock has 7 warning signs investors should review.

P3 Health Partners's revenue for the three months ended in Mar. 2026 was $386 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $1,472 Mil. P3 Health Partners's Revenue per Share for the three months ended in Mar. 2026 was $45.91. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $377.74.

Warning Sign:

P3 Health Partners Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of P3 Health Partners was -20.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -29.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 8 years, P3 Health Partners's highest 3-Year average Revenue per Share Growth Rate was 127.80% per year. The lowest was -29.30% per year. And the median was -15.80% per year.


P3 Health Partners  (NAS:PIII) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


P3 Health Partners Revenue Related Terms


P3 Health Partners Revenue Historical Data

* Premium members only.

The historical data trend for P3 Health Partners's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

P3 Health Partners Revenue Chart

P3 Health Partners Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial 0.00 1,049.47 1,266.38 1,500.46 1,459.08

P3 Health Partners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 373.23 355.79 345.25 384.81 386.39

PIII vs EHSI, CDIX, DCGO: Revenue Comparison

For the Medical Care Facilities subindustry, P3 Health Partners's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


P3 Health Partners Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's Revenue distribution charts can be found below:

* The bar in red indicates where P3 Health Partners's Revenue falls into.


PIII
44GF Score
P3 Health Partners Inc PIII
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

P3 Health Partners Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,472 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $1,472 Mil mean?
P3 Health Partners (PIII) has a Revenue of $1,472 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on P3 Health Partners and its competitors.
Is P3 Health Partners' Revenue too high?
P3 Health Partners' current Revenue is $1,472 Mil. Overall, P3 Health Partners has a GF Score™ of 44/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' Revenue compare to EHSI and CDIX?
P3 Health Partners' Revenue of $1,472 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on P3 Health Partners and its competitors. P3 Health Partners's current Revenue is $1,472 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.07, compared to a current price of $10.59 — trading 16.8% above its estimated fair value. The current Revenue is $1,472 Mil. P3 Health Partners' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For P3 Health Partners (PIII), the current Revenue is $1,472 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is P3 Health Partners (PIII) Overvalued in 2026?

Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued. The current stock price of $10.59 is trading 16.8% above its estimated GF Value™ of $9.07. GuruFocus considers P3 Health Partners to be Modestly Overvalued.

Key valuation signals for PIII:

  • Revenue: $1,472 Mil
  • GF Value™: $9.07 vs. price of $10.59 (16.8% above fair value)
  • GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


P3 Health Partners Business Description

Address 2370 Corporate Circle, Suite 300, Henderson, NV, USA, 89074
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
44GF Score

Get the complete analysis for PIII

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.59
Price
$9.07
GF Value